Last Posted: Apr 03, 2019
- Biomedical risk assessment as an aid for smoking cessation.
Clair Carole et al. The Cochrane database of systematic reviews 2019 Mar 3CD004705 - Applications of machine learning in addiction studies: A systematic review.
Mak Kwok Kei et al. Psychiatry research 2019 Mar 27553-60 - Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach.
Sluiter Reinier L et al. European addiction research 2018 24(5) 245-254 - 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.
Bierut Laura J et al. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2019 Mar - ANCO-GeneDB: annotations and comprehensive analysis of candidate genes for alcohol, nicotine, cocaine and opioid dependence.
Hu Ruifeng et al. Database : the journal of biological databases and curation 2018 2018 - From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?
Ragia Georgia et al. Pharmacogenomics 2018 19(6) 513-516 - Predicting those at risk for opioid abuse
M McFadden, November 1,2018 - Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.
Blum Kenneth et al. Biomedical journal of scientific & technical research 2018 Jan 2(2) 1-4 - From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology.
Gallo Cantafio Maria Eugenia et al. High-throughput 2018 Oct 7(4) - Gutted about opioids- The microbiome may have an influence on addiction
W Yan, Nature Medicine, October 30, 2018
.png)
No hay comentarios:
Publicar un comentario